Muken Ross sold 422 shares of SOPHiA GENETICS SA at $8.33 for −$3.52k on Sep 21, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Chief Executive Officer
Chief Executive Officer
Filed Sep 22, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$3,515.26Shares × reported price
Shares traded
422Ordinary Shares
Price per share
$8.33Reported price. Read footnotes for ranges.
% of reported position traded
0.06%This security and ownership context
Holdings after
670,229Direct
Trade date
Sep 21, 2026Sell
Filed
Sep 22, 2026, 4:02 PM ET1-day reporting delay
Accession
0001840706-26-000317Code S · Transaction 227404
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 670,651 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

SOPH price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
SOPH · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +7.2%1w ago −2.6%1d ago +1.5%
Returns since7d +2.9%30d −8.9%90d180d1y

Footnotes in full

F1: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on September 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.